Dr. Park has accumulated over 30 years of work experience in therapeutics development from early target discovery through late-stage drug development in both academic and industry settings. Previously, he served as an adjunct Professor at the College of Veterinary Medicine at Jeju National University, where he published over 35 research articles. Before joining ILIAS Biologics, he worked for major pharmaceutical corporations including GDFI Inc., SK Biopharmaceuticals, and Jeil Pharmaceuticals as Project Leader and Executive Director. Now, as the Head of the Development center of ILIAS Biologics, Dr. Park is leading the company’s efforts for the development of innovative therapeutics with patented exosome-based drug delivery platforms.

Dr. Park earned his Ph.D. in Neuropharmacology from Seoul National University, College of Medicine.